Rhythm Biosciences: Losses Narrow, Income Falls

Rhythm Biosciences Ltd. (AU:RHY) has released an update.

Rhythm Biosciences Limited reports a 48% decline in other income and a 17% decrease in loss after tax for the year ended June 30, 2024, showing signs of improvement from the previous year. No dividends were issued during the period, and the net tangible assets per share significantly decreased from 2.46 cents to 0.14 cents. The company’s financial statements have been audited with an unqualified opinion.

For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.